GenScript Biotech Global Forum London 2025

(1) GenScript Biotech Global Forum London 2025

The field of gene and cell therapy is experiencing unprecedented growth, driven by groundbreaking innovations in life sciences, medicine, and robust investment from global capital markets. To foster progress in this transformative field, the GenScript Biotech Global Forum London 2025 will convene on Thursday, 20 November 2025 in London, held in conjunction with the Jefferies London Healthcare Conference. With four successful iterations in San Francisco and London, the Forum has established itself as a premier gathering for top minds in cell and gene therapy.

Under the theme THE NEXT ERA OF CGT IS HERE, we are honored to invite leading experts from academia, industry, investment, and regulatory agencies to discuss the latest advancements in research, technological breakthroughs and evolving regulatory landscapes. This forum will bring together global thought leaders united in the mission to accelerate therapies that improve patient lives.

(2) Hot Topics

• NAVIGATING THE FUTURE OF CELL THERAPY: EVALUATING VARIED PATHWAYS IN CELL THERAPY INNOVATION FOR COMPREHENSIVE SECTOR INSIGHTS
• LATEST PROGRESS AND FUTURE OUTLOOK IN GENE THERAPY AND MRNA
• FROM LAB TO PATIENT: OVERCOMING CMC BARRIERS IN CELL AND GENE THERAPY MANUFACTURING
• INNOVATION AND INVESTMENT FOR CGT ​

(3) Schedule: (GMT Time Zone)

• Registration: 12:00 P.M.-1:30 P.M.

• Program: 1:30 P.M.- 6:35 P.M.

• Reception: 6:35 P.M.- 8:00 P.M.

(4) Part of Confirmed Speakers

• Alex Bloom, CTO, Aviadobio
• Luigi Calzolai, Project Leader Nanomedicine at Joint Research Center of European Commission
• Anna Cereseto, Head of Molecular Virology lab, Alia Therapeutics
• Daniela/Oskar, Partners, Biogeneration ventures
• Miguel Forte, M.D., Ph.D., President of International Society for Cell & Gene Therapy (ISCT); ARM Board Member, Chief Executive Officer of Kiji Therapeutics
• Miroslav Gasparek, CEO, Sensible Biotechnologies
• Ying Huang, CEO, Legend Biotech
• Stephen Hansen, Director of Biopharma Intelligence, BioCentury
• Marten Hansen, Head of Cell Therapy Innovation, Sanquin Blood Bank
• Carl June, Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine, Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine, Director of the Parker Institute for Cancer Immunotherapy , University of Pennsylvania
• Sergio Linares, leaders for automation platform, Sanofi
• Craig Mello, RNA Therapeutics Institute, Howard Hughes Medical Institute, and Blais Chair of Molecular Medicine Awarded the 2006 Nobel Prize in Physiology or Medicine
• John Maher, Chief Scientific Officer, Leucid Bio
• Marcello Maresca, Senior Director, Genome Engineering, AstraZeneca
• Julen Oyarzabal, CSO & Founder, Syngoi Technologies
• Paula Rio, CIEMAT
• Paul Stoffels, Former Chief Scientific Officer, Johnson & Johnson. Co-founder, Former CEO - Chair Galapagos NV
• Robin Shattock, Head of Future Vaccines Research Hub, ICL
• Klaus Wagenbauer, CEO, Plectonic

We would like to extend to you a cordial invitation to join your peers at what promises to be a unique opportunity to share insights and collaborate on the global advancement of cell and gene therapy in London in November 2025.

*Program schedule and speakers are subject to change.

Highlights of Series Forum